NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Signals

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Kintara Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 65 days ( -8.84 %
Last Price $0.215 0 %
Performance History
7 Days
$0.215 $0.215
0%
30 Days
$0.215 $0.215
0%
12 Mos
$0.158 $0.215
36.33%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.215 - $0.215
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 15, 2025 - 2 days
RSI Short Pivot Signal Buy Very Low Nov 04, 2024 - 50 days
Short MA 3 mos Sell Low Oct 21, 2024 - 60 days
Long MA 3 mos Sell Medium Nov 29, 2024 - 32 days
Short/Long MA 3 mos Sell Medium Nov 29, 2024 - 32 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 65.35
Signal Type Signal Value Importance Data
Trend - 12 mos 43.74 % Very High Width: 163.52 %
Pred. range - 12 mos $0.215 - $0.566 High -0.296 % - 162.73 %
Short MA 12 mos Sell Very High Nov 08, 2024 - 46 days
Long MA 12 mos Buy Very High Nov 08, 2024 - 46 days
Short/Long MA 12 mos Buy Very High Nov 08, 2024 - 46 days
Pivot Long Buy Low Oct 17, 2024 - 62 days
RSI Long Pivot Signal Buy Low Nov 13, 2024 - 43 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE